Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized phase 4 study of individualized docetaxel dosing using free plasma level monitoring after a mini-dose pharmacokinetic test
2007-005461-35Phase 4Terminated
- Sponsor
- Vall d'Hebron University Hospital
- Start
- Dec 2007
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of docetaxel in breast cancer, non-small cell lung cancer (NSCLC), castration-resistant prostate cancer (CRPC), gastric cancer (GC), Cervical Cancer (CC), sponsored by Vall d'Hebron University Hospital. Started Dec 2007; status: terminated.
02
Drugs
docetaxel
03
Conditions
breast cancernon-small cell lung cancer (NSCLC)castration-resistant prostate cancer (CRPC)gastric cancer (GC)Cervical Cancer (CC)
Beyond the preview
Go deeper on 2007-005461-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005461-35.